Alpha 2.0
Login Register
» Authors » Simona Ricciolino

Simona Ricciolino

Explore the profile of Simona Ricciolino including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 34
Followers 0
Related Specialties
Gastroenterology
General Medicine
Biomedical Engineering
Top 10 Co-Authors
Antonio Rispo
Nicola Imperatore
Anna Testa
Fabiana Castiglione
Olga Maria Nardone
Roberto De Sire
Marta Patturelli
Imma Di Luna
Oriana Olmo
Giulio Calabrese
Published In
Dig Liver Dis
Therap Adv Gastroenterol
Int Med Case Rep J
J Gastroenterol Hepatol
Biomedicines
Affiliations
Soon will be listed here.
Recent Articles
1.
Segmental colitis associated with diverticulosis (SCAD) in a colorectal cancer screening population: Prevalence, endoscopic features and oncological outcomes
Imperatore N, Cordone G, Martorelli L, Rispo A, Familiari V, Musto D, et al.
Dig Liver Dis . 2024 Jul; 57(1):134-140. PMID: 39013710
Background: Segmental colitis associated with diverticulosis (SCAD) is characterized by a chronic inflammatory response involving the inter-diverticular colonic mucosa, sparing the rectum and the right colon. Aims: to assess the...
2.
"Per ELISA": Time to adopt anti-transglutaminase/deamidated gliadin peptide diagnostic combination in coeliac disease of adults?
Rispo A, Calabrese G, Toro B, Olmo O, Ricciolino S, Cantisani N, et al.
Dig Liver Dis . 2024 Mar; 56(6):988-993. PMID: 38538378
Background: Anti-endomysial antibodies (EMA) and anti-tissue transglutaminases (a-tTg) play a pivotal role in coeliac disease (CD) diagnosis. Deamidated anti-gliadin peptides (DGP) were added to the CD diagnostic workup. Aims: We...
3.
"The crackers challenge": A reassuring low-dose gluten challenge in adults on gluten-free diet without proper diagnosis of coeliac disease
Rispo A, Guarino A, Siniscalchi M, Imperatore N, Santonicola A, Ricciolino S, et al.
Dig Liver Dis . 2024 Mar; 56(9):1517-1521. PMID: 38521669
Background: Gluten-free diet (GFD) is the one therapy in coeliac disease (CeD). Unfortunately, some patients adopt GFD before the diagnostic work-up. The guidelines suggest a 14-day gluten intake > 3...
4.
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers
Castiglione F, Imperatore N, Testa A, De Sire R, Nardone O, Ricciolino S, et al.
Therap Adv Gastroenterol . 2022 Jul; 15:17562848221110643. PMID: 35898191
Background: While mucosal healing (MH) and transmural healing (TH) predict relevant clinical outcomes in Crohn's disease (CD), little is known about the real significance and clinical impact of deep remission...
5.
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease
Rispo A, De Sire R, Mainenti P, Imperatore N, Testa A, Maurea S, et al.
Inflamm Bowel Dis . 2022 Jun; 29(4):563-569. PMID: 35666249
Background: Diagnosis of Crohn's disease (CD) requires ileo-colonoscopy (IC) and cross-sectional evaluation. Recently, "echoscopy" has been used effectively in several settings, although data about its use for CD diagnosis are...
6.
Effect of Gliadin Stimulation on HLA-DQ2.5 Gene Expression in Macrophages from Adult Celiac Disease Patients
Farina F, Pisapia L, Laezza M, Serena G, Rispo A, Ricciolino S, et al.
Biomedicines . 2022 Jan; 10(1). PMID: 35052743
Macrophages play an important role in the pathogenesis of celiac disease (CD) because they are involved in both inflammatory reaction and antigen presentation. We analyzed the expression of CD-associated HLA-DQ2.5...
7.
Ultrasonography-Based Management of Sclerosing Mesenteritis: From Diagnosis to Follow-Up
De Sire R, Imperatore N, DArmiento M, Coccoli P, Di Luna I, Ricciolino S, et al.
Int Med Case Rep J . 2021 Apr; 14:187-190. PMID: 33814933
Sclerosing mesenteritis (SM) is an idiopathic disorder affecting mesentery, characterized by fat necrosis, chronic inflammation and fibrosis. The clinical presentation varies from asymptomatic cases to acute abdomen. The diagnosis is...
8.
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease
Rispo A, Imperatore N, Guarino M, Tortora R, Alisi A, Cossiga V, et al.
Liver Int . 2020 Dec; 41(4):788-798. PMID: 33319459
Background And Aims: Coeliac disease (CD) is considered a high-risk condition for developing non-alcoholic fatty liver disease (NAFLD) and other related metabolic disorders, particularly after commencing gluten-free diet (GFD). Recently,...
9.
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting
Imperatore N, Foggia M, Patturelli M, Rispo A, Calabrese G, Testa A, et al.
J Gastroenterol Hepatol . 2020 Dec; 36(7):1859-1868. PMID: 33283312
Background And Aim: Infective issues about anti-tumor necrosis factor (TNF)-α agents in inflammatory bowel disease (IBD) remain controversial, especially when compared with nonbiological treatments. This study aimed to evaluate the...
10.
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak
Nardone O, Rispo A, Testa A, Imperatore N, Pellegrini L, Guarino A, et al.
Therap Adv Gastroenterol . 2020 Oct; 13:1756284820959586. PMID: 33024453
Background: With the interruption of elective activity during the coronavirus disease 2019 (COVID-19) pandemic, a reorganisation of health care for patients with inflammatory bowel disease (IBD) was warranted. We aimed...